Advertisement

Journal of Urban Health

, Volume 89, Issue 6, pp 1004–1016 | Cite as

Patterns of Prescription Drug Misuse among Young Injection Drug Users

  • Stephen E. Lankenau
  • Michelle Teti
  • Karol Silva
  • Jennifer Jackson Bloom
  • Alex Harocopos
  • Meghan Treese
Article

Abstract

Misuse of prescription drugs and injection drug use has increased among young adults in the USA. Despite these upward trends, few studies have examined prescription drug misuse among young injection drug users (IDUs). A qualitative study was undertaken to describe current patterns of prescription drug misuse among young IDUs. Young IDUs aged 16–25 years who had misused a prescription drug, e.g., opioids, tranquilizers, or stimulants, at least three times in the past 3 months were recruited in 2008 and 2009 in Los Angeles (n = 25) and New York (n = 25). Informed by an ethno-epidemiological approach, descriptive data from a semi-structured interview guide were analyzed both quantitatively and qualitatively. Most IDUs sampled were both homeless and transient. Heroin, prescription opioids, and prescription tranquilizers were frequently misused in the past 30 days. Qualitative results indicated that young IDUs used prescription opioids and tranquilizers: as substitutes for heroin when it was unavailable; to boost a heroin high; to self-medicate for health conditions, including untreated pain and heroin withdrawal; to curb heroin use; and to reduce risks associated with injecting heroin. Polydrug use involving heroin and prescription drugs resulted in an overdose in multiple cases. Findings point to contrasting availability of heroin in North American cities while indicating broad availability of prescription opioids among street-based drug users. The results highlight a variety of unmet service needs among this sample of young IDUs, such as overdose prevention, drug treatment programs, primary care clinics, and mental health services.

Keywords

Prescription drug misuse Injection drug use Young adults 

Notes

Acknowledgments

This research was supported by a grant to Stephen Lankenau from the National Institute of Drug Use (DA021299).

References

  1. 1.
    Johnston, LD, O’Malley, PM, Bachman, JG, Schulenberg, JE. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2009. NIH Publication No. 10-7583. Bethesda, MD: National Institute on Drug Abuse; 2010.Google Scholar
  2. 2.
    Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. NSDUH Series H-38A: DHHS Publication No. SMA 10-4856. Rockville, MD: Office of Applied Studies; 2010.Google Scholar
  3. 3.
    Chatterjee S, Tempalski B, Pouget ER, Cooper HL, Cleland CM, Friedman SR. Changes in the prevalence of injection drug use among adolescents and young adults in large U.S. metropolitan areas. AIDS Behaviors. 2011; 15: 1570–1578.CrossRefGoogle Scholar
  4. 4.
    Center for Disease Control and Prevention. Unintentional Drug Poisoning in the United States: A CDC Issue Brief. National Center for Injury Prevention and Control. 2010. http://www.cdc.gov/HomeandRecreationalSafety/pdf/poison-issue-brief.pdf. Accessed November 19, 2010.
  5. 5.
    Davidson PJ, Ochoa KC, Hahn JA, Evans JL, Moss AR. Witnessing heroin-related overdoses: the experiences of young injectors in San Francisco. Addiction. 2002; 97(12): 1511–1516.PubMedCrossRefGoogle Scholar
  6. 6.
    Fuller CM, Vlahov D, Arria AM, Ompad DC, Garfein R, Strathdee SA. Factors associated with adolescent initiation of injection drug use. Public Health Rep. 2001; 116(Suppl 1): 136–145.PubMedCrossRefGoogle Scholar
  7. 7.
    Page K, Hahn JA, Evans J, et al. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Acquir Immune Defic Syndr. 2009; 200(8): 1216–1226.Google Scholar
  8. 8.
    Hagan H, Pouget ER, Williams IT, et al. Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. J Infect Dis. 2010; 201(3): 378–385.PubMedCrossRefGoogle Scholar
  9. 9.
    Miller CL, Wood E, Spittal PM, et al. The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users. J Acquir Immune Defic Syndr. 2004; 36(1): 743–749.PubMedCrossRefGoogle Scholar
  10. 10.
    Ochoa KC, Davidson PJ, Evans JL, Hahn JA, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend. 2005; 80(3): 297–302.PubMedCrossRefGoogle Scholar
  11. 11.
    Roy E, Boudreau JF, Leclerc P, Boivin JF, Godin G. Trends in injection drug use behaviors over 10 years among street youth. Drug Alcohol Depend. 2007; 89(2–3): 170–175.PubMedCrossRefGoogle Scholar
  12. 12.
    Lankenau SE, Sanders B, Jackson-Bloom J, et al. Prevalence and patterns of prescription drug misuse among young ketamine injectors. J Drug Issues. 2007; 37(3): 717–736.PubMedCrossRefGoogle Scholar
  13. 13.
    Evans JL, Hahn JA, Lum PJ, Stein ES, Page K. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug Alcohol Depend. 2009; 101(3): 152–157.PubMedCrossRefGoogle Scholar
  14. 14.
    Hagan H, Campbell JV, Thiede H, et al. Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior. Drug Alcohol Depend. 2007; 91(Suppl 1): S48–S55.PubMedCrossRefGoogle Scholar
  15. 15.
    Firestone M, Fischer B. A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: behaviours, preferences and drug availability. Harm Reduction J. 2008; 5: 30.CrossRefGoogle Scholar
  16. 16.
    Lankenau SE, Teti M, Silva K, Jackson-Bloom J, Harocopos A, Treese M. Initiation into prescription opioid misuse amongst young injection drug users. Int J Drug Policy. 2012; 23: 37–44.PubMedCrossRefGoogle Scholar
  17. 17.
    Roy E, Arruda N, Bourgois P. The growing popularity of prescription opioid injection in downtown Montreal: new challenges for harm reduction. Subst Use Misuse. 2011; 46(9): 1142–1150.PubMedCrossRefGoogle Scholar
  18. 18.
    Agar M. Recasting the “ethno” in “epidemiology”. Med Anthropol. 1996; 16: 391–403.PubMedCrossRefGoogle Scholar
  19. 19.
    Clatts MC, Welle DL, Goldsamt LA, Lankenau SE. An ethno-epidemiological model for the study of trends in illicit drug use: reflections on the ‘emergence’ of crack injection. Int J Drug Policy. 2002; 13(4): 285–296.PubMedCrossRefGoogle Scholar
  20. 20.
    Pach IA, Gorman EM. An ethno-epidemiological approach for the multi-site study of emerging drug abuse trends: the spread of methamphetamine in the United States of America. Bull Narc. 2002; 54: 87–102.Google Scholar
  21. 21.
    Lankenau SE, Clatts MC. Drug injection practices among high-risk youths: the first shot of ketamine. J Urban Health. 2004; 81(2): 232–248.PubMedCrossRefGoogle Scholar
  22. 22.
    Lankenau SE, Sanders B. Patterns of ketamine use among young injection drug users. J Psychoactive Drugs. 2007; 39(1): 21–29.PubMedCrossRefGoogle Scholar
  23. 23.
    Hathazi D, Lankenau SE, Sanders B, Jackson Bloom J. Pregnancy and sexual health among homeless young injection drug users. J Adolesc. 2009; 32(2): 339–355.PubMedCrossRefGoogle Scholar
  24. 24.
    Sanders B, Lankenau SE, Jackson-Bloom J. Putting in work: qualitative research on substance use and other risk behaviors among gang youth in Los Angeles. Subst Use Misuse. 2010; 45(5): 736–753.PubMedCrossRefGoogle Scholar
  25. 25.
    Clatts MC, Davis WR, Atillasoy A. Hitting a moving target: the use of ethnographic methods in the evaluation of AIDS outreach programs for homeless youth in NYC. Qualitative methods in drug abuse and HIV research. NIDA Res Monogr. 1995; 157: 117–135.PubMedGoogle Scholar
  26. 26.
    Watters J, Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Probl. 1989; 36: 416–430.CrossRefGoogle Scholar
  27. 27.
    Biernacki P, Waldorf D. Snowball sampling: problems and techniques of chain referral sampling. Socio Meth Res. 1981; 10: 141–163.Google Scholar
  28. 28.
    Penrod J, Preston DB, Cain RE, Starks MT. A discussion of chain referral as a method for sampling hard-to-reach populations. J Transcult Nurs. 2003; 14(2): 100–107.PubMedCrossRefGoogle Scholar
  29. 29.
    Lankenau SE, Sanders B, Jackson-Bloom J, et al. First injection of ketamine among young injection drug users (IDUs) in three U.S. cities. Drug Alcohol Depend. 2007; 87(2–3): 183–193.PubMedCrossRefGoogle Scholar
  30. 30.
    Hernandez S, Nelson L. Prescription drug abuse: insight into the epidemic. Clin Pharmacol Ther. 2010; 88(3): 307–317.PubMedCrossRefGoogle Scholar
  31. 31.
    National Institute on Drug Abuse. Epidemiologic Trends in Drug Abuse. Proceedings of the Community Epidemiology Work Group. Highlights and Executive Summary, Vol. I. Bethesda, MD: Division of Epidemiology, Services Research, and Prevention; 2011.Google Scholar
  32. 32.
    Popova S, Patra J, Mohapatra S, Fischer B, Rehm J. How many people in Canada use prescription opioids non-medically in general and street drug using populations? Can J Public Health. 2009; 100(2): 104–108.PubMedGoogle Scholar
  33. 33.
    Davis WR, Johnson BD. Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend. 2008; 92(1–3): 267–276.PubMedCrossRefGoogle Scholar
  34. 34.
    Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med. 2007; 8(2): 171–183.PubMedCrossRefGoogle Scholar
  35. 35.
    Daniulaityte RD, Carlson RG, Kenne D. Initiation to pharmaceutical opioids and patterns of misuse: preliminary qualitative findings obtained by the Ohio Substance Abuse Monitoring Network. J Drug Issues. 2006; 36(4): 787–808.CrossRefGoogle Scholar
  36. 36.
    Rigg KK, Ibanez GE. Motivations for non-medical prescription drug use: a mixed methods analysis. J Subst Abuse Treatment. 2010; 39(3): 236–247.CrossRefGoogle Scholar
  37. 37.
    Quintero G. Rx for a party: a qualitative analysis of recreational pharmaceutical use in a collegiate setting. J Am Coll Health. 2009; 58(1): 64–70.PubMedCrossRefGoogle Scholar
  38. 38.
    Agar M, Bourgois P, French J, Murdoch O. Heroin addict habit size in three cities: context and variation. J Drug Issues. 1998; 28(4): 921–940.Google Scholar
  39. 39.
    Bardhi F, Sifaneck S, Johnson BD, Dunlap E. Pills, thrills and bellyaches: case studies of prescription pill use and misuse among marijuana/blunt smoking middle class young women. Contemp Drug Probl. 2007; 34(1): 53–101.PubMedGoogle Scholar
  40. 40.
    McCabe SE, Boyd CJ, Teter CJ. Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend. 2009; 102(1–3): 63–70.PubMedCrossRefGoogle Scholar
  41. 41.
    Leri F, Bruneau J, Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction. 2003; 98(1): 7–22.PubMedCrossRefGoogle Scholar
  42. 42.
    Lankenau SE, Sanders B, Jackson-Bloom J, et al. Migration patterns and substance use among young homeless travelers. In: Thomas YF, Richardson D, Cheung I, eds. Geography and Drug Addiction. New York: Springer; 2008: 65–83.CrossRefGoogle Scholar
  43. 43.
    Boddiger D. Fentanyl-laced street drugs “kill hundreds”. Lancet. 2006; 368(9535): 569–570.PubMedCrossRefGoogle Scholar
  44. 44.
    Bazazi AR, Yokell M, Fu JJ, Rich JD, Zaller ND. Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users. J Addict Med. 2011; 5: 175–180.PubMedCrossRefGoogle Scholar
  45. 45.
    Woody GE, Poole SA, Subramaniam G, et al. Extended vs short-term buprenorphine–naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA. 2008; 300(17): 2003–2011.PubMedCrossRefGoogle Scholar
  46. 46.
    Des Jarlais DC, Perlis TE, Settembrino JM. The use of electronic debit cards in longitudinal data collection with geographically mobile drug users. Drug Alcohol Depend. 2005; 77(1): 1–5.PubMedCrossRefGoogle Scholar
  47. 47.
    Lankenau SE, Sanders B, Hathazi D, Jackson-Bloom J. Recruiting and retaining mobile young injection drug users in a longitudinal study. Subst Use Misuse. 2010; 45(5): 684–699.PubMedCrossRefGoogle Scholar

Copyright information

© The New York Academy of Medicine 2012

Authors and Affiliations

  • Stephen E. Lankenau
    • 1
  • Michelle Teti
    • 2
  • Karol Silva
    • 1
  • Jennifer Jackson Bloom
    • 3
  • Alex Harocopos
    • 4
  • Meghan Treese
    • 3
  1. 1.Department of Community Health and PreventionSchool of Public Health, Drexel UniversityPhiladelphiaUSA
  2. 2.School of Health ProfessionsUniversity of MissouriColumbiaUSA
  3. 3.Division of Research on Children, Youth and FamiliesChildren’s Hospital Los AngelesLos AngelesUSA
  4. 4.National Development and Research Institutes, Inc.New YorkUSA

Personalised recommendations